Regulus therapeutics inc. (RGLS)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Sep'11
Revenues:
Revenue from Contract with Customer, Excluding Assessed Tax

6

18

18

18

6,778

18

18

18

18

-

18

18

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenues

-

-

-

-

-

-

-

-

-

-

-

-

18

-

204

483

489

10,860

1,865

3,834

4,200

4,219

1,083

736

1,631

5,454

6,118

4,759

3,238

3,238

2,809

3,309

3,344

3,809

Operating expenses:
Research and development

3,119

2,090

2,440

1,836

5,983

5,255

6,879

10,013

11,828

10,465

12,697

14,278

15,752

14,980

14,554

18,007

16,764

12,794

10,965

19,201

13,427

10,474

10,173

10,795

9,604

8,231

7,106

7,722

6,883

5,608

5,248

4,883

4,603

3,875

General and administrative

2,422

2,363

2,571

2,850

3,533

2,745

2,993

3,349

3,773

3,259

2,736

7,057

3,959

4,782

4,842

3,664

5,103

5,427

4,245

5,814

3,644

3,278

2,569

2,954

2,732

1,884

1,917

1,723

1,905

1,934

1,093

984

921

907

Total operating expenses

5,541

4,453

5,011

4,686

9,516

8,000

9,872

13,362

15,601

13,724

15,433

21,335

19,711

19,762

19,396

21,671

21,867

18,221

15,210

25,015

17,071

13,752

12,742

13,749

12,336

10,115

9,023

9,445

8,788

7,542

6,341

5,867

5,524

4,782

Loss from operations

-5,535

-4,435

-4,993

-4,668

-2,738

-7,982

-9,854

-13,344

-15,583

-13,706

-15,415

-21,317

-19,693

-19,744

-19,192

-21,188

-21,378

-7,361

-13,345

-21,181

-12,871

-9,533

-11,659

-13,013

-10,705

-4,661

-2,905

-4,686

-5,550

-4,304

-3,532

-2,558

-2,180

-973

Other income (expense):
Interest and other income

79

40

87

191

56

-24

201

118

164

194

160

184

214

237

237

180

190

170

335

151

199

105

86

97

100

85

72

63

72

36

20

27

27

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28

Interest and other expense

489

498

517

538

578

497

620

621

605

994

580

603

546

508

560

90

24

31

6

7

8

8

10

10

11

-

7

18

-

-46

110

90

93

97

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,738

-

-

-

Loss from valuation of convertible note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-1,811

-12,732

1,785

953

-2,124

2,642

671

-2,697

-1,761

-

-331

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

Loss before income taxes

-5,945

-4,893

-5,423

-5,015

-3,260

-8,503

-10,273

-13,847

-16,024

-14,506

-15,835

-21,736

-20,025

-20,015

-19,515

-21,098

-21,212

-7,222

-13,016

-21,037

-14,491

-22,168

-9,798

-11,973

-12,740

-1,945

-2,169

-7,338

-7,239

-6,860

-5,691

-2,621

-2,246

-1,041

Income tax benefit

-8

0

0

1

0

61

0

0

1

-58

-7

-128

-4

5

4

-8

-5

4

-16

-2

-4

2

0

-2

1

-18

-5

10

-10

17

-6

-22

1

4

Net Income (Loss) Attributable to Parent

-5,937

-4,893

-5,423

-5,016

-3,260

-8,564

-10,273

-13,847

-16,025

-14,448

-15,828

-21,608

-20,021

-20,020

-19,519

-21,090

-21,207

-7,226

-13,000

-21,035

-14,487

-22,168

-9,798

-11,973

-12,741

-1,927

-2,164

-7,348

-7,229

-6,877

-5,685

-2,599

-2,247

-1,045

Unrealized gain on short-term investments, net

-

-

0

0

-

-

16

47

7

-31

-16

10

26

-9

-30

9

40

-32

40

-2

58

-131

-24

17

-43

28

37

-44

15

-29

10

-32

66

-76

Comprehensive loss

-

-

-5,423

-5,016

-

-

-10,257

-13,800

-16,018

-14,479

-15,844

-21,598

-19,995

-20,029

-19,549

-21,081

-21,167

-7,258

-12,960

-21,037

-14,429

-22,299

-9,822

-11,956

-12,784

-1,899

-2,127

-7,392

-7,214

-6,906

-5,675

-2,631

-2,181

-1,121

Net loss per share, basic and diluted (in dollars per share)

-0.25

-0.21

-0.26

-0.30

-0.31

-0.97

-1.18

-1.59

-1.85

-8.57

-2.11

-0.41

-0.38

-17.42

-0.37

-0.40

-0.40

-0.13

-0.25

-0.41

-0.29

-

-

-

-0.30

-

-

-

-0.20

-

-

-10.78

-13.06

-11.68

Weighted average shares used to compute basic and diluted net loss per share (in shares)

24,064

21,106

20,849

16,705

10,379

8,808

8,703

8,693

8,668

-88,600

7,506

53,182

52,990

-140,721

52,835

52,782

52,710

52,510

51,990

51,073

50,071

-

-

-

42,690

-

-

-

35,872

-

-

241,223

171,998

89

Basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.23

-0.28

-

-

-0.05

-0.20

-

-

-15.98

-

-

-

Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.26

-0.29

-

-

-0.07

-0.20

-

-

-15.98

-

-

-

Basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

43,406

43,362

-

-

40,154

35,994

-

-

355,735

-

-

-

Diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

44,855

44,799

-

-

41,555

35,994

-

-

355,735

-

-

-

Revenue under collaborations
Revenue from Contract with Customer, Excluding Assessed Tax

6

-

18

18

6,778

-

18

18

100

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-